www.fdanews.com/articles/126617-generex-creates-own-regulatory-reality
Generex Creates Own Regulatory Reality
April 29, 2010
Generex Biotechnology CEO Anna Gluskin may have run afoul of U.S. regulations governing experimental
drugs when she spoke to investors earlier this year about the prospects for the company’s Oral-lyn insulin spray.
TheStreet
TheStreet